Thoracic Cancer (Jan 2020)

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients

  • Ying Ding,
  • Lihua Zhang,
  • Lingchuan Guo,
  • Chunyan Wu,
  • Jianhua Zhou,
  • Yongchun Zhou,
  • Jie Ma,
  • Xiao Li,
  • Pan Ji,
  • Ming Wang,
  • Weidong Zhu,
  • Chenxi Shi,
  • Sanen Li,
  • Wei Wu,
  • Wei Zhu,
  • Desheng Xiao,
  • Chunyan Fu,
  • Qiuyan He,
  • Rui Sun,
  • Xinru Mao,
  • Analyn Lizaso,
  • Bing Li,
  • Han Han‐Zhang,
  • Zhihong Zhang

DOI
https://doi.org/10.1111/1759-7714.13208
Journal volume & issue
Vol. 11, no. 1
pp. 103 – 112

Abstract

Read online

Abstract Background Distinction in the mutational profile between the common histological types, lung adenocarcinoma (LUAD) and squamous cell lung carcinoma (LUSC) has been well‐established. However, comprehensive mutation profiles of the predominant histological subtypes within LUAD and LUSC remains elusive. Methods We analyzed the mutational profile of 318 Chinese NSCLC patients of adenocarcinoma and squamous cell carcinoma predominant subtypes from seven hospitals using capture‐based ultra‐deep sequencing of 68 lung cancer‐related genes. Results Of the 318 NSCLC patients, 215 were diagnosed with LUAD and 103 with LUSC. Adenocarcinoma in situ and acinar adenocarcinoma were the most predominant subtypes of LUAD. On the other hand, keratinizing squamous cell carcinoma was the most predominant subtype of LUSC. Among the LUAD subtypes, EGFR sensitizing mutations were most prevalent in the invasive lepidic subtype. More than half of the patients with preinvasive adenocarcinoma in situ, minimally invasive, acinar, micropapillary and papillary subtypes were also EGFR‐mutants. Patients with colloidal, invasive mucinous, and fetal subtypes had the least number of EGFR mutations. Moreover, KRAS mutations were prevalent in patients with invasive mucinous, colloid, enteric and solid subtypes. A total of 90% of the LUSC patients harbor mutations in TP53, wherein all patients except five with nonkeratinizing were TP53 mutants. PIK3CA amplifications were most prevalent in keratinizing, followed by basaloid and nonkeratinizing subtypes. Conclusion These data suggest that the mutational profiles among the predominant histological subtypes were very distinct, which provided a reliable tool to improve treatment decisions.

Keywords